Medical News

RSS

New Rush clinic brings trained clinicians to care for patients with pulmonary hypertension

Cardiologists and pulmonologists at Rush University Medical Center have teamed up to provide a new and better approach to treating patients with pulmonary hypertension, a disease affecting the heart and lungs. The new Rush Pulmonary Hypertension Clinic brings together a multidisciplinary team of clinicians with specialized training to care for patients with this very complex disease.

16 Feb 2011

MDI releases major software update to Viewpoint Analytics

MDI has released a major enhancement to Viewpoint Analytics, a powerful web-based healthcare data warehousing, management, and reporting solution. Among the biggest additions to Viewpoint's suite of capabilities, MDI has integrated McKesson's CareEnhance Disease Monitor solution, improved Viewpoint's innovative medical risk scoring, and enhanced overall reporting speed and performance through data cubing.

16 Feb 2011

Microsoft, Visionshare partner to enhance health information transaction between physicians, patients

VisionShare, the nation's largest and most trusted healthcare information network, announced today that it is working with Microsoft Corp. to enhance the transaction of health information from physicians to their patients based on security protocols endorsed by the Office of the National Coordinator's Direct Project.

16 Feb 2011

AMT 2010 total net income increases to EUR 1.4 million

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today reported its results for the year to December 31, 2010.

16 Feb 2011

Also in global health news: Gates Foundation global health head to step down; drug, medical supply shortages in Gaza; food security in N. Korea

Tachi Yamada, president of the global health program at the Bill & Melinda Gates Foundation, on Monday announced he would step down in June after five years serving in the position, the Associated Press/Seattle Post-Intelligencer reports.

16 Feb 2011

Majority of parents continue to give OTC cough and cold medicines to children under 2

Research has linked over-the-counter cough and cold products to poisoning or death in hundreds of children, ages 2 and younger. Studies have also shown that these medicines do little to control symptoms. As a result, in 2008, the United States Food and Drug Administration formally recommended that OTC cough and cold products not be given to children under age 2.

16 Feb 2011

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?

16 Feb 2011

GAVI chair calls for greater reductions in vaccine prices for developing countries

On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).

16 Feb 2011

Sanofi-aventis enters definitive agreement to acquire Genzyme

Sanofi-aventis and Genzyme Corporation announced today that they have entered into a definitive agreement under which sanofi-aventis is to acquire Genzyme for $74.00 per share in cash, or approximately $20.1 billion.

16 Feb 2011

Study: Expedited medical device reviews account for majority of recalls

The analysis, which was published in the Archives of Internal Medicine, connected the Food and Drug Administration's most urgent medical device recalls with high-risk devices that were subject to "speedy" review.

16 Feb 2011

Halozyme-Roche announce initiation of Phase 3 subcutaneous MabThera trial in follicular NHL

Halozyme Therapeutics, Inc. and Roche today announced the first patient received subcutaneous MabThera (rituximab), an anticancer biologic, in a Phase 3 registration trial using Enhanze technology.

16 Feb 2011

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

Viral Genetics, Inc. announced today that lead researcher Dr. M. Karen Newell Rogers and Advisor Mr. Richard Gerstner will receive the Lauren F. Brooks Hope Award, presented by Time for Lyme, Inc.

16 Feb 2011

Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide

Sanofi-aventis and Sunnybrook Health Sciences Centre announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.

16 Feb 2011

AHF condemns budget move by House Republicans for global AIDS programs

AIDS Healthcare Foundation, which provides AIDS medical care and services to more than 152,000 individuals in 26 countries worldwide, today strongly condemned a move by House Republicans, who on Friday proposed slashing President Obama's 2011 funding for global AIDS programs by $813 million.

16 Feb 2011

Medicare pay cut for docs already drawing fire

Critics said the method used in the budget blueprint would cause serious problems. But some news reports indicate the inclusion of this Medicare "doc fix" would help build support within the physician community for the president's health care agenda.

16 Feb 2011

Study: RAPI tool more effective at predicting future alcohol dependence of teen-age drinkers

A widely used index for assessing adolescent drinking-related problems has been found to be effective at predicting the future alcohol dependence of teen-age drinkers, according to an Indiana University study which also found that the association was stronger for adolescent female drinkers.

16 Feb 2011

Fibrocell Science sells $7.8 million Series D convertible preferred stock

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that between December 8, 2010 and February 9, 2011 it entered into agreements with certain accredited investors, pursuant to which the Company sold to the purchasers in the aggregate approximately $7.8 million of the Company's Series D convertible preferred stock, which is convertible into shares of common stock at a conversion price of $0.50 per share.

16 Feb 2011

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

Researchers from Jefferson's Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial oxidative stress-a culprit in driving tumor growth.

16 Feb 2011

New report examines impact of Affordable Care Act on national immunization policy

A new report issued by the George Washington University School of Public Health and Health Services and funded by the U.S. Department of Health and Human Services analyzes the impact of Affordable Care Act on national immunization policy. The report examines a wide range of reforms that are aimed at strengthening immunization policy and practice.

16 Feb 2011

CR still under consideration as House GOP vehicle to defund health law

House Speaker John Boehner, R-Ohio, said this plan is still under discussion. Meanwhile, as the House considers this Continuing Resolution, which would provide current year funding for the federal government, it will do so under new rules for debate.

16 Feb 2011

Medical News

New Rush clinic brings trained clinicians to care for patients with pulmonary hypertension

MDI releases major software update to Viewpoint Analytics

Microsoft, Visionshare partner to enhance health information transaction between physicians, patients

AMT 2010 total net income increases to EUR 1.4 million

Also in global health news: Gates Foundation global health head to step down; drug, medical supply shortages in Gaza; food security in N. Korea

Majority of parents continue to give OTC cough and cold medicines to children under 2

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

GAVI chair calls for greater reductions in vaccine prices for developing countries

Sanofi-aventis enters definitive agreement to acquire Genzyme

Study: Expedited medical device reviews account for majority of recalls

Halozyme-Roche announce initiation of Phase 3 subcutaneous MabThera trial in follicular NHL

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide

AHF condemns budget move by House Republicans for global AIDS programs

Medicare pay cut for docs already drawing fire

Study: RAPI tool more effective at predicting future alcohol dependence of teen-age drinkers

Fibrocell Science sells $7.8 million Series D convertible preferred stock

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

New report examines impact of Affordable Care Act on national immunization policy

CR still under consideration as House GOP vehicle to defund health law

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News